Clinical Trial Update: Pomegranate Products for Prevention of Common Cold [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pomegranate products for prevention of the common cold has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Pomegranate products (pomegranate extract)

Snippet

Sponsor: Texas Heart Institute | Conditions: Influenza, Common Cold | Phase 3 | Status: COMPLETED